title: Treatment of daytime urinary incontinence: A standardization document from the International Children's Continence Society.
abstract: This article is a standardization document of the International Children's Continence Society (ICCS); it represent a consensus of ICCS on the management of pediatric daytime urine incontinence (DUI).
  
  
  
  This document was designed and written by a multi-disciplinary core group of authors appointed by the ICCS' board.
  
  
  
  Based on evidence of studies and the experience of experts, the treatment guideline of DUI is assembled in this standardization document. Guidelines and the algorithm of management include non-pharmacological treatment (urotherapy), as well as the pharmacological therapy and other modalities that are presented for DUI in general, as along with recommendations for individual conditions.
  
  
  
  The final document is not a systematic literature review. It includes relevant research when available as well as experts' opinion on the current understanding of daytime incontinence in children. This document illustrates that specific treatment of DUI based on an exact diagnosis is effective. The mainstay of treatment is urotherapy, but a combination of treatment modalities is often necessary. Neurourol. Urodynam. 36:43-50, 2017. © 2015 Wiley Periodicals, Inc.
authors.affiliation: Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.|Medical College of Buddhist Tzu, Chi University, Hualien, Taiwan.
authors.forename: Shang-Jen
authors.initials: SJ
authors.lastname: Chang
authors.affiliation: Department of Urology, Section of Pediatric Urology, Ghent University, Ghent, Belgium.
authors.forename: Erik
authors.initials: E
authors.lastname: Van Laecke
authors.affiliation: Department of Urology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Stuart B
authors.initials: SB
authors.lastname: Bauer
authors.affiliation: Department of Child and Adolescent Psychiatry, Saarland University Hospital, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: von Gontard
authors.affiliation: Division of Urology, Hospital for Sick Children and Department of Surgery, University of Toronto, Toronto, Ontario.
authors.forename: Darius
authors.initials: D
authors.lastname: Bagli
authors.affiliation: Department of Rehabilitation, The Royal Melbourne Hospital, Melbourne, Australia.
authors.forename: Wendy F
authors.initials: WF
authors.lastname: Bower
authors.affiliation: Department of Urology, Section of Pediatric Urology, Ghent University, Ghent, Belgium.
authors.forename: Catherine
authors.initials: C
authors.lastname: Renson
authors.affiliation: Department of Urology, Shiga University of Medical Science, Otsu, Japan.
authors.forename: Akihiro
authors.initials: A
authors.lastname: Kawauchi
authors.affiliation: Division of Urology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.|Medical College of Buddhist Tzu, Chi University, Hualien, Taiwan.
authors.forename: Stephen Shei-Dei
authors.initials: SS
authors.lastname: Yang
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000465:Algorithms; D001905:Botulinum Toxins / Q000627:therapeutic use; D002648:Child; D032921:Consensus; D000072700:Conservative Treatment; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D012015:Reference Standards; D014549:Urinary Incontinence / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D053202:Urinary Incontinence, Urge / Q000188:drug therapy / Q000628:therapy
chemical_list: D000317:Adrenergic alpha-Antagonists; D018727:Muscarinic Antagonists; D001905:Botulinum Toxins
keywords: child; daytime incontinence; non-pharmacological treatment; pharmacological treatment; urotherapy